Nazione: Stati Uniti
Lingua: inglese
Fonte: NLM (National Library of Medicine)
IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7), CALCIUM ASCORBATE (UNII: 183E4W213W) (ASCORBIC ACID - UNII:PQ6CK8PD0R), CYANOCOBALAMIN (UNII: P6YC3EG204) (CYANOCOBALAMIN - UNII:P6YC3EG204), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)
Trigen Laboratories, LLC
IRON
IRON 150 mg
ORAL
Taron Forte Capsules are contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy.
Taron Forte Capsules are packaged in child-resistant bottles of 100 capsules. PRODUCT CODE 13811-042-10.
Dietary Supplement
TARON FORTE- IRON, CALCIUM ASCORBATE, CYANOCOBALAMIN, AND FOLIC ACID CAPSULE TRIGEN LABORATORIES, LLC ---------- TARON FORTE CAPSULES SUPPLEMENT FACTS Taron Forte Multivitamin/Mineral with Iron capsules are indicated for the distinctive nutritional requirements of persons being treated for iron deficiencies by a physician. CONTRAINDICATIONS Taron Forte Capsules are contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindications to iron therapy. WARNINGS WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING PRODUCTS IS A LEADING CAUSE OF FATAL POISONING IN CHILDREN UNDER 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, CALL A DOCTOR OR POISON CONTROL CENTER IMMEDIATELY. PRECAUTIONS GENERAL: The type of anemia and the underlying cause or causes should be determined before starting therapy with Taron Forte Capsules. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where B is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia assessment, such that hematologic remission can occur while neurological manifestations remain progressive. PEDIATRIC USE: Safety and effectiveness of this product have not been established in pediatric patients. ADVERSE REACTIONS Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools, and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid. The clinical cause of acute iron overdosage can be variable. Initial symptoms may include: abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehy Leggi il documento completo